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Human health relies on the composition of microbiota in an individual’s gut and the synthesized
metabolites that may alter the gut environment. Gut microbiota and faecal metabolites are involved
in several gastrointestinal diseases. In this study, 16S rRNA-specific denaturing gradient gel
electrophoresis and quantitative PCR analysis showed that the mean similarity of total bacteria
was significantly different (P,0.001) in faecal samples from patients with irritable bowel
syndrome (IBS; n511) and from non-IBS (nIBS) patients (n58). IBS subjects had a significantly
higher diversity of total bacteria, as measured by the Shannon index (H9) (3.36,H9,4.37,
P50.004), Bacteroidetes and lactobacilli; however, less diversity was observed for Bifidobacter
(1.7, H9,3.08, P,0.05) and Clostridium coccoides (0.9, H9,2.98, P50.007). In this study,
no significant difference was found in total bacterial quantity (P.0.05). GC/MS-based
multivariate analysis delineated the faecal metabolites of IBS from nIBS samples. Elevated levels
of amino acids (alanine and pyroglutamic acid) and phenolic compounds (hydroxyphenyl acetate
and hydroxyphenyl propionate) were found in IBS. These results were highly correlated with the
abundance of lactobacilli and Clostridium, which indicates an altered metabolism rate associated
with these gut micro-organisms. A higher diversity of Bacteroidetes and Lactobacillus groups in
IBS faecal samples also correlated with the respective total quantity. In addition, these changes
altered protein and carbohydrate energy metabolism in the gut.
INTRODUCTION
Irritable bowel syndrome (IBS) is a functional disorder of
the gastrointestinal (GI) tract that results in abdominal
pain, altered bowel habits and irregular stool character-
istics. IBS cases have been reported worldwide, and it has
been shown that adults and adolescents are more prone to
developing IBS. In western European and North America,
10–15% of the population have IBS, and 6.6% of the
Korean population are affected (Han et al., 2006).
Although the aetiology of IBS has not yet been identified,
it is believed that genetic, environmental, psycho-social and
physiological factors, as well as an individual’s diet, may be
responsible for IBS (Ohman & Simre ´n, 2007). In addition,
recent studies have shown differences in the microbiota
between IBS diarrhoea patients and healthy controls
(Krogius-Kurikka et al., 2009). Short-chain fatty acids
were found to be at higher levels in diarrhoea-predominant
IBS patients than in other IBS patients (Mortensen et al.,
1987).
Intestinal micro-organisms play various roles in human
health such as complex food digestion, metabolizing drugs,
detoxifying toxic compounds, producing essential vitamins
and preventing colonization of pathogens. Most of the
micro-organisms found in the GI tract are anaerobic
bacteria, which are uncultivable under standard laboratory
conditions. The type and number of bacteria in the GI tract
varies depending on age, gender, geographical origin
(Mueller et al., 2006) and environmental factors, such as
diet and dietary supplements (Kajander et al., 2009).
Abbreviations: DGGE, denaturing gradient gel electrophoresis;
Dsc, Dice similarity coefficient; GI, gastrointestinal; H9, Shannon index;
IBS, irritable bowel syndrome; KACC, Korean Agricultural Culture
Collection; KCTC, Korean Collection for Type Cultures; nIBS, non-
irritable bowel syndrome; PCA, principal component analysis; PLS-DA,
partial least-squares discriminant analysis; qPCR, quantitative real-time
PCR.
3These authors contributed equally to this work.
The GenBank/EMBL/DDBJ accession numbers for the 16S rRNA gene
sequences of the IBS faecal microbiota studied are HQ018603–
HQ018637.
Tables of patient demographics and IBS faecal metabolites, and a figure
showing phylogenetic relationships, are available as supplementary
material with the online version of this paper.
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bacteria present in the normal human GI tract, and the
latter was reported in lower numbers in constipation-
predominant IBS patients (Rajilic ´-Stojanovic ´ et al., 2007).
A variety of factors determine the intestinal residential and
transient species populations (Heavey & Rowland, 1999).
Therefore, the composition and proportion of individual
bacterial populations, as well as metabolites, are continu-
ously changing; in addition, the bacterial community
depends on diet. As the GI tract harbours complex
microbial, digested and non-digested food materials,
micro-organisms cannot respond independently. Rather,
group-specific bacteria act as a consortium and coordinate
other competing microbials as well as the host metabolism,
either positively or negatively. The general estimation of
diversity and the selected beneficial and predominant com-
munity size may be correlated with healthy and diseased GI
tracts. Metagenomics-based studies on microbial genomes
in the GI tract have provided a more thorough under-
standing of the indigenous micro-organisms and their
contribution to IBS. PCR was previously combined with
denaturing gradient gel electrophoresis (DGGE) to provide
more detailed information on microbial composition and
diversity, and their specific roles in IBS (Rajilic ´-Stojanovic ´
et al., 2007).
Recent studies have shown that human symbiotic gut
microbiota modulate the microbial phenotype and meta-
bolites in faecal and urinary samples (Li et al., 2008). Thus,
altered faecal metabolites not only reflect the status of the
gut microbiome community but also bridge the relation-
ships between symbiotic microbes and health. GC-MS has
been applied successfully to analyse and interpret multi-
parametric metabolic responses in living systems, and
pathophysiological and environmental perturbations (Gao
et al., 2009; Scherling et al., 2010). Multivariate statistical
analysis by partial least-squares discriminant analysis
(PLS-DA) has been employed to elucidate significant
differences and to screen for potential biomarkers that
could account for the variance of biological samples (Gao
et al., 2009).
Very little work has been conducted to compare the faecal
microbial community and metabolites among IBS patients
in the Korean population. A better understanding of the
prevalent bacterial community and metabolites in faecal
samples might be useful for either eliminating or restoring
certain species to improve one’s health. Therefore, in the
present study, we analysed and compared the indigenous
faecal microbial community of IBS and non-IBS (nIBS)
Korean subjects with faecal metabolites. The data presented
here provide details about the complex GI bacterial shift
and faecal metabolites, which could ultimately help
delineate IBS from nIBS.
METHODS
Study subjects. Faecal samples were collected from 11 IBS (6 male, 5
female) and 8 nIBS (6 male, 2 female) patients, aged 18–74 years
(mean 47.5 years) who were advised to follow a normal diet without
any medications (see Supplementary Table S1 available with the
online journal). The Rome II standard was followed to select the
study subjects, and the exclusion criteria included inflammatory
bowel disease (ulcerative colitis, Crohn’s disease and Behcet’s disease),
GI malignancy and acute GI bleeding.
Bacterial community DNA extraction. The collected faecal samples
were frozen immediately (,5 min) at 220 uC and stored at 280 uC
until used. Faecal community DNA was extracted as described in
published studies (Apajalahti et al., 1998) and purified using a
PowerClean DNA clean-up kit (Mo Bio Laboratories). The DNA
concentration and purity were determined using a Nanodrop
spectrophotometer (Nanodrop Technologies).
PCR amplification of total bacteria. Total bacterial DNA was used
for the amplification of the V3–V5 region of the 16S rRNA gene using
universal primers GC341F (341F with a GC clamp) and 907R as
shown in Table 1. The PCR mixture (25 ml) contained 5 ng template
DNA, 0.18 mM each primer, 0.25 mM dNTPs, 0.75 U Ex Taq
polymerase (Takara) and reaction buffer with 2 mM MgCl2. The
V3–V5 regions were amplified using GC clamp primers with an initial
denaturation step of 95 uC for 5 min, followed by touchdown PCR: 9
cycles of 94 uC for 30 s, 64 to 56 uC for 28 s at a ramp of 21 uC per
cycle and 72 uC for 50 s; and then 15 cycles of 94 uC for 30 s, 56 uC
for 28 s and 72 uC for 50 s, with a final elongation at 72 uC for
15 min. Two microlitres of the amplicon was analysed by (1.2%, w/v)
agarose gel electrophoresis prior to DGGE analysis.
Group-specific bacteria amplification. The composition of
selected probiotic and predominant bacterial groups such as
Bacteroidetes, Bifidobacter, Clostridium coccoides and Lactobacillus
groups was studied using group-specific amplifications to compare
the individual communities with the total bacteria. The primers and
PCR conditions for group-specific amplification are described in
Table 1.
DGGE. DGGE was performed using a DCode universal mutation
detection system (Bio-Rad). Briefly, PCR samples were applied to
polyacrylamide gels in 16 TAE with a urea and formamide denatur-
ing gradient [7 M urea and 40% (v/v) formamide corresponded to
the 100% gradient] as described by Muyzer & Smalla (1998).
Electrophoresis was carried out at 60 uC with a constant voltage, as
described in Table 1. The gels were stained with SYBR Green I
(Invitrogen), observed under UV transillumination and documented
with a Molecular Imager GelDoc system (Bio-Rad). The PCR
amplicons of type strains and a representative study sample were
included as markers to provide a possible indication of the identities
and to compare bands between the gels. The following type strains
were obtained from the Korean Agricultural Culture Collection
(KACC) or Korean Collection for Type Cultures (KCTC): Bacteroides
fragilis (KCTC 3688), Bacteroides vulgatus (KCTC 2639),
Bifidobacterium breve (KCTC 3220), Bifidobacterium longum (KACC
20597), Campylobacter jejuni (KCTC 5327), Clostridium clostridio-
forme (KCTC 5572), Enterococcus faecalis (KACC 13807), Escherichia
coli (KCTC 1682), Lactobacillus acidophilus (KACC 12419),
Lactobacillus casei (KACC 12413) and Ruminococcus productus
(KCTC 3695).
Analysis of microbial community fingerprints and sequencing.
Similarities between the DNA fingerprints were detected using
Fingerprinting II software (Bio-Rad). Clustering was performed
using the Dice similarity coefficient (Dsc) and UPGMA. The general
biodiversity of the Shannon index (H9) and the concentration of the
dominance or Simpson index (D or S) were calculated based on
the number of bands and their relative intensities among the
individual samples. Distinct bands (total of 40) were excised,
K. Ponnusamy and others
818 Journal of Medical Microbiology 60Table 1. Universal and group-specific 16S rRNA gene-targeted primers and PCR/DGGE conditions
Primer Sequence (5§A3§) Amplicon
size (bp)
PCR DGGE Target group Reference
Annealing
temp (6C)
Acrylamide
(%)
Gradient
(%)
Run
341F CCTACGGGAGGCAGCAGCCG* 585 56 6 36–54 90 V/16 h Universal bacteria (16S
rRNA gene variable
regions V3–V5)
Muyzer & Smalla (1998)
907R TCAATTCMTTTGAGTTT
BfraF GGTGTCGGCTTAAGTGCCAT 140 62 8 40–65 135 V/5 h Bacteroides–Prevotella–
Porphyromonas
Rinttila ¨ et al. (2004)
BfraR CGGA(C/T)GTAAGGGCCGTGC*
BifF GCGTGCTTAACACATGCAAGTC 125 60 8 40–70 135 V/5 h Bifidobacteria Zwielehner et al. (2009)
BifR CACCCGTTTCCAGGAGCTATT*
CoccoF AAATGACGGTACCTGACTAA 440 53 6 38–58 70 V/16 h Clostridium coccoides Matsuki et al. (2002)
CoccoR CTTTGAGTTTCATTCTTGCGAA*
LacF AGCAGTAGGGAATCTTCCA 380 56 8 38–53 70 V/16 h Lactobacilli Vanhoutte et al. (2004)
LacR ATTYCACCGCTACACATG*
F, Forward; R, reverse.
*GC clamp, CGCCCGGGGCGCGCCCCGGGCGGGGCGGGGGCACGGGGGG.
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9amplified by PCR with primers 341F (without the GC clamp) and
907R, purified with an AccuPrep PCR purification kit (Bioneer) and
sequenced (Macrogen). The mean, SD and SEM were calculated for
each experiment. Student’s t-test (unequal variances, two-tailed)
was applied for statistical analysis and P values ,0.05 were
considered significant. Multivariate statistics was performed using
the supervised principal component analysis (PCA) using SIMCA-P
+
version 12 (Umetrics).
Phylogenetic analysis. The sequences obtained were checked
using ChromasPro (Technelysium) and Sequence scanner version
1.0 (Applied Biosystems) to remove redundant sequences. The
partial 16S rRNA gene sequences were compared with those in
GenBank (www.ncbi.nlm.nih.gov), the Ribosomal Database Project
II (http://rdp.cme.msu.edu) and Eztaxon (www.eztaxon-e.org).
Phylogenetic trees were constructed based on the neighbour-
joining method by performing 1000 bootstrap analyses using
MEGA4.
Quantitative real-time PCR (qPCR). The qPCR mixture (25 ml)
consisted of 16 SYBR Premix Ex Taq II (Takara), ROX reference
dye II, 0.18 mM each group-specific primer, 2 mM MgCl2 and 10 ng
DNA template. The amplification programme comprised an initial
denaturation step at 95 uC for 30 s, followed by 35 cycles of
denaturation at 95 uC for 15 s, primer annealing at 55–68 uC (Table
2) for 20 s and extension at 72 uC for 45 s. The fluorescence data
were collected at the end of each PCR cycle and experiments were
carried out in triplicate using a 7500 Fast Real-time PCR system
(Applied Biosystems). Melting-curve analysis was carried out to
determine the specificity of the PCR products. The melting curves
were obtained by slowly heating the sample from 60 to 95 uCa ta
rate of 0.1 uCs
21, with continuous fluorescence collection. The
fluorescence was compared with the external standard, and the
efficiency of amplification of each primer was tested with the
appropriate positive and negative controls. The type strains were
used to construct the standard curve and the results were converted
into the log value of the target bacterial 16S rRNA gene copy
numbers (g faecal sample)
21.
Faecal metabolite extraction and derivatization. Faecal samples
(0.1 g) were homogenized with 300 ml methanol (4 uC) for
metabolomic analysis. The samples were vortexed for 1 min,
ultrasonicated for 30 min and vortexed again for 1 min prior to
centrifugation at 16000 g for 15 min at 4 uC. Faecal extracts, which
were derivatized in two steps to protect carbonyl functions, were
dried in a freezing dryer (12 h). First, the dried samples were
dissolved in 100 ml of a solution of methoxyamine hydrochloride in
pyridine (20 mg ml
21; Sigma) and incubated at 75 uC for 30 min.
The volatility of polar compounds was increased by exchanging
acidic protons against the trimethylsilyl group using 100 ml N-
methyl-N-trimethylsilyltrifluoroacetamide (Sigma) at 70 uCf o r
30 min.
GC-MS-based metabolite profiling. Each 1 ml of the derivatives
were injected in a split mode (1:25) into a Varian CP-3800 GC
system coupled with a Varian 4000 ion-trap electron ionization/
chemical ionization mass spectrometric detector system. A VF-1MS
capillary column (30 m60.25 mm) with 0.25 mm coating and
equipped with an integrated 10 m guard column (Varian) was used
to separate the derivative metabolites. The initial oven temperature
was held at 100 uC for 2 min and then ramped to 300 uC at a rate of
5 uC min
21 and held for 7 min. Helium (purity .99.999%) was used
as a carrier gas at a constant flow rate of 1 ml min
21. The
temperatures of the electron ionization ion source and injector were
set to 200 and 250 uC, respectively. Electron impact ionization
(70 eV) was utilized, and mass data were collected in a full-scan mode
(m/z 50–1000). The metabolites were identified by comparison with
the NIST 2005 database version 2.0 (FairCom).
Metabolite data analysis. The raw GC-MS data were converted
into CDF (NetCDF) files and processed using the XCMS tool-
box for automatic peak detection and alignment. For multi-
variate statistical analysis, the XCMS output was further processed
using Microsoft Excel. The data were arranged on a three-
dimensional matrix consisting of arbitrary peak index (retention
time–m/z pairs), sample names (observations) and peak area
(variables).
The resulting three-dimensional data table was entered into the
SIMCA-P+ version 12.0 software package for multivariate statistical
analysis. The supervised PLS-DA model was used to maximize
metabolite variations and identify significantly altered metabolites
responsible for such variations (Gao et al., 2009). These values
were further validated by Student’s t-test using STATISTICA version
7.0 (StatSoft). The metabolites with variable importance projec-
tion (VIP) values .1.0 and P values ,0.05 (threshold) were
selected as metabolites that could discriminate between IBS and
nIBS patients.
Table 2. List of primers and PCR conditions used for quantification of faecal bacteria using qPCR
Target group* Sequence (5§A3§) Size
(bp)
Annealing
temp (6C)
Mg
2+
(millimoles l
”1)
Reference
Universal bacteriaD F: ACTCCTACGGGAGGCAG 468 60 2 Zwielehner et al. (2009)
R: GACTACCAGGGTATCTAATCC
Bacteroides–Prevotella–Porphyromonasd See Table 1 140 68 2 Rinttila ¨ et al. (2004)
Bifidobacteria§ See Table 1 125 60 2 Zwielehner et al. (2009)
Clostridium coccoides|| F: CGGTACCTGACTAAGAAGC 429 55 2 Rinttila ¨ et al. (2004)
R: AGTTTYATTCTTGCGAACG
Lactobacilli" F: AGCAGTAGGGAATCTTCCA 341 58 2 Walter et al. (2001)
R: CACCGCTACACATGGAG
F, Forward; R, reverse.
*The following type strains were used as positive controls: D, Enterococcus faecalis (KACC 13807); d, Bacteroides vulgatus (KCTC 2639);
§, Bifidobacterium longum; (KACC 20597); ||, R. productus (KCTC 3695); ", L. acidophilus (KACC 12419).
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Faecal microbial community
PCR amplification and the DGGE profile of total bacteria
of the representative faecal samples had a band similarity
coefficient of .95%. Thus, these samples were determined
to be basically identical, and the individual sample aliquots
were pooled together and used. Significant differences were
observed in the banding pattern between IBS (predominant
number of bands: 16.9±3.8) and nIBS (9.9±3.5) subjects
(P,0.001) as well as between the faecal samples. The
DGGE pattern showed that diarrhoea-predominant and
constipation-predominant faecal samples were mixed in
the IBS samples. The intensity of the bands was
approximately 42% higher in the IBS subjects than in
the nIBS subjects.
Diversity and dominant bacteria. DGGE profiles were
used to calculate similarities between the samples and
with the selected groups. Dsc was calculated and clustered,
and each sample was compared with the other samples
present in the same subject. The mean similarity indices
of total bacteria revealed that greater biological variability
of predominant bacteria was higher in the IBS samples
(59.3±12%) than in the nIBS samples (42.2±11.4%)
(Fig. 1). The statistical analysis also indicated a significant
difference (P,0.001) between the IBS and nIBS sub-
jects. The highest microbial diversity (3.36,H9,4.37,
P50.004; Fig. 2a) and dominance (0.88,D,0.947,
P,0.05; Fig. 2b) were observed in the IBS sample. In
the qPCR analysis, no significant difference (P.0.05) in
the total quantity was found (Fig. 3). Three main clusters
were observed in the DGGE profile, where 90% of the
IBS samples were clustered together. Among the IBS
samples, most of the males and females were clustered
separately (Fig. 4a). The diverse dataset was grouped
based on the variance, and nIBS samples were separated
from IBS samples in the first two principal components
(PC1 and PC2), which were approximately 26 and 31%,
respectively (Fig. 4b).
The majority of the dominant band sequences (52.5%)
displayed .97% similarity with known sequences in the
database. The most abundant bacterial groups detected
were members of the Firmicutes, Proteobacteria,
Actinobacteria and Bacteroidetes (see Supplementary Fig.
S1 with the online journal). Among the dominant bands,
86% (12/14) had .98% similarity with the known
sequences in the database and were found in both of
the study groups. Fingerprinting analysis showed that
Eubacterium biforme was present exclusively in the IBS
subjects (Fig. 4a). The band intensity of Eubacterium
biforme varied among the samples (2.5–25%) and its
relative quantity varied from 1.3 to 9.5% among the
individual faecal samples.
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Fig. 1. Dice coefficient pairwise comparisons of total bacteria
(using universal bacterial primers) and Bacteroidetes, Bifido-
bacterium, Clostridium coccoides and Lactobacillus groups in
the IBS versus nIBS faecal community. *, P,0.05; **, P,0.001.
White bars, nIBS; grey bars, IBS.
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Fig. 2. Diversity indices derived from DGGE fingerprinting of
16S rRNA gene-coding regions for total bacteria and the
Bacteroidetes, Bifidobacterium, Clostridium coccoides and Lacto-
bacillus groups. (a) Shannon index of general diversity (H9). (b)
Simpson index of dominance (D or S). *, P,0.05; **, P,0.01.
White bars, nIBS; grey bars, IBS.
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Prevotella–Porphyromonas) group. The overall gene
diversity was 15% higher in the IBS samples than in the
nIBS samples (Fig. 2a). Based on qPCR analysis, the
content of Bacteroidetes was 15% higher in the IBS samples
than in the nIBS samples. Bacteroidetes-specific DGGE
profiles were not consistently observed among the subjects
and they varied dramatically between samples as well as
between the two groups. As the diversity was sample
specific, 64% of the IBS and 50% of the nIBS subjects were
grouped into mixed clusters. In the PCA analysis, nIBS
was grouped into PC1 (51%). Different species of
Prevotella were identified with .96% identity using the
database. Bacteroides xylanisolvens was identified in clus-
tered IBS samples (64%), with a relative concentration
ranging from 7.5 to 20% in the individual samples.
Bacteroides fragilis was mostly associated with the male IBS
samples (4–20%).
Lactobacillus group. The high Dsc values suggested that
all the nIBS subjects shared a major portion of the band
set, whilst the IBS samples had unique bands, as indicated
by the low Dsc values (Fig. 1). The Lactobacillus diversity
was higher in the IBS samples than in the nIBS samples
(Fig. 2). Similarly, the total quantity was about 15%
higher in the IBS subjects than the nIBS subjects. The
variances of the IBS subjects were grouped by PC1 (30%).
Lactobacillus ruminis was commonly identified in more
than half of the IBS samples and had a relative abundance
of 5–8% in the individual IBS samples and a 14–31%
mean band intensity. Weissella confusa was widely
distributed in all the faecal samples, but a higher band
density was observed in the nIBS (57%) than the IBS
(43%) samples.
The PCR-DGGE fingerprint showed that the mean number
of bifidobacteria was higher in the nIBS samples (75%)
than the IBS samples. A similar trend was observed for its
diversity (22%; P,0.05) but not in its dominance (11%;
P,0.05) for the nIBS samples (Fig. 2a, b). Bifidobacterium
pseudocatenulatum was commonly observed in the faecal
samples and had a relative abundance of 6–31% in the
individual samples. The variation in mean band intensity
was 60 and 40% in the IBS and nIBS samples, respectively.
Bifidobacterium breve, Bifidobacterium longum subsp.
infantis and Bifidobacterium pseudolongum subsp. pseudo-
longum were also observed in the faecal samples.
Clostridium coccoides group. Clostridium coccoides and
related species were detected in all the faecal community
DNA. In the analysis of Dsc, a mean of 29 and 40.9% was
determined for the IBS and nIBS samples, respectively,
where the latter was 29% higher, which was numerically
significant (P,0.05) (Fig. 1). The Shannon index reflected
the complete microbial community, and a mean value of
2.73 was observed in the nIBS samples, which was twice as
large as the value for the IBS samples (P50.007; Fig. 2a).
The Simpson index of dominance was also 41% higher in
the nIBS sample (P,0.05; Fig. 2b). However, there was no
difference between the subjects in terms of the total
quantity of bacteria. Blautia wexlerae (about 94% simi-
larity) was commonly found in most of the samples (IBS,
73%; nIBS, 78%) and constituted up to 48% among the
individual samples.
Non-targeted metabolite analysis of the faecal
extracts
A total of 1313 peaks were observed when the metabolite
profile of the faecal extracts was analysed by XCMS from
the GC-MS ion chromatograms. The significant differ-
ences between IBS and nIBS samples were identified using
the mass peak intensities of all the detected metabolites,
which were expressed in a score plot for PLS-DA (Fig. 5a)
and loading S-plots (Fig. 5b). Both upregulation and
downregulation of metabolites were observed in IBS
versus nIBS samples. The results are summarized in
Supplementary Table S2 (available with the online
journal).
Metabolic signature of IBS and gut microbiota
The statistical characterization of selected metabolites was
related to the identified gut microbiota. Increased levels of
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Fig. 3. Box and whisker plot showing the quantitative estimation of
universal bacteria and group-specific bacteria determined by
qPCR. IBS samples were compared with nIBS samples and the
values were expressed as the mean log 16S rRNA gene copy
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purines were observed in IBS faecal samples when
compared with nIBS controls. The IBS faecal samples
clearly showed higher levels of alanine, pyroglutamic acid,
aminobutyric acid, glutamic acid, hydroxyphenyl acetate,
hydroxyphenyl propionate, glyceric acid and purines than
those in nIBS (Fig. 6). In addition, significantly different
metabolites (P,0.05) were observed in IBS, including
glucopyranose and hydrocinnamic acid; however, these
metabolites were not comparable to the currently available
gut microbiota due to insufficient literature on gut bacteria
and its metabolites. These differences in metabolites
between IBS and nIBS faeces were highly correlated with
changes in the gut microbiota and provide powerful
evidence of the microbial diversity in IBS patients.
DISCUSSION
The microbiota play a crucial role in the maintenance and
regular function of the GI ecosystem. GI microbial
communities are stable over a period of time in healthy
people with a normal diet; moreover, the population of
bacteria depends on individual subjects. Recent studies
have shown that there is a high prevalence of IBS in Asians,
which is comparable with the levels found in Western
populations.
Analysis of the faecal bacterial diversity suggested that the
species in the IBS samples were evenly distributed. The mean
similarity between the subjects, as well as in the nIBS cases,
was low (,50%), in agreement with published reports
(Codling et al., 2010). Three variable regions (V3–V5) of the
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profile, which implied a low similarity. In contrast, V3-
specific amplicons showed the greatest mean similarity
(59.2%)inthefaecalbacterialcommunityinKoreansamples
(Nam et al., 2008). The Dice similarity and UPGMA analyses
of the total bacterial DGGE profiles indicated that the nIBS
samples were clustered into two groups.
Firmicutes and Bacteroidetes are the most dominant
beneficial microbiota present in the normal human GI
tract; in addition, the latter has been shown to be higher in
IBS samples (Krogius-Kurikka et al., 2009). The total
Bacteroides–Prevotella–Porphyromonas quantity determined
in this study was in agreement with previous studies, which
have reported a relatively increased abundance of these
bacteria in elderly people and in those with infectious
colitis (Zwielehner et al., 2009). Faecal carbohydrates and
insufficient available nitrogen are the limiting factors for
GI bacterial metabolism. Prevotella produces toxic materi-
als under limiting nitrogen conditions, which is challenging
Fig. 6. Hypothetical diagram showed a comparison of the faecal metabolites found and the major gut microbiota. The relative
changes in IBS and nIBS faecal metabolites were derived from the GC-MS peak area and expressed as box and whisker plots.
Positive and negative correlations are indicated as solid and dashed lines, respectively.
Fig. 5. PLS-DA score plots (a) and PLS-DA loading S-plots (b) of significantly different metabolites derived from GC-MS
analysis datasets of faecal extracts. (a) $, nIBS; m, IBS. (b) $, nIBS-related biomarkers; m, IBS-related biomarkers;
&, unidentified biomarkers.
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studies have emphasized the prevalence of Bacteroides sp. in
other intestinal disorders such as inflammatory bowel
disease (Rehman et al., 2010). Faecalibacterium prausnitzii
produces aminobutyric acid, which is a crucial energy
source for colonic epithelium and may enhance the
integrity of the epithelial barrier and modulate the GI
immune system (Lara-Villoslada et al., 2006). Butyrate has
also been reported to modulate inflammation in inflam-
matory bowel disease patients, possibly by downregulating
the production of pro-inflammatory cytokines. F. praus-
nitzii might be important not only for its provision of
butyrate to the host but also due to the release of high
interleukin (IL-10/IL-12) cytokine levels (Schwiertz et al.,
2010).
In the present study, Eubacterium biforme (belonging to
Clostridium cluster XVI) was identified only in IBS
subjects. It has been observed in the mucus of patients
with Crohn’s disease and in lymphonodular hyperplasia
of children (8.33%) (Harrington et al., 2008). The high
level of the sugar alcohol glyceric acid could have been
released from triacylglycerols associated with the colon
wall; in addition, the increased level of Eubacterium
biforme in IBS may be responsible for the release of
glyceric acids in the faeces, which indicates a shift in
energy metabolism.
The genus Clostridium consists of a heterogeneous group
of micro-organisms that can adapt to diverse habitats
(Woodmansey et al., 2004). The Simpson index of
dominance was higher in nIBS samples, which is in
contrast to other intestinal diseases, and it was not found to
be significantly different between Crohn’s disease and
control groups (Scanlan et al., 2006). A similar instability
of the Clostridium group has been observed, and no inter-
individual differences between IBS samples were noted
(Codling et al., 2010). Direct sequencing has demonstrated
that the loss of normal anaerobic bacteria is responsible for
the reduction in microbial diversity in IBS (Ott et al.,
2004).
Bifidobacterial diversity experiments have shown that IBS
samples are clustered separately from the higher diversity of
nIBS subjects. The normal dietary fibre-consuming group
contained more bifidobacteria than the group consuming
less fibre (Benno et al., 1989). A decrease in the amount of
dietary fibres consumed led to a reduction in bifidobacteria,
which caused constipation in patients with IBS. Bifido-
bacterium is a well-documented taxon with regard to its
phylogenetic and phenotypic characteristics (Schwiertz
et al., 2010). Although the diversity was significantly higher
in nIBS, no major difference was observed in terms of
total number of bifidobacteria. Bifidobacterium breve and
Lactobacillus plantarum probiotic combinations have been
reported to reduce the severity of IBS symptoms, and the
prebiotics oligofructose and inulin selectively stimulate bi-
fidobacterial growth and reduce constipation, predominant
in IBS patients (Saggioro, 2004).
With regard to the Lactobacillus group, neither the IBS nor
nIBS subjects clustered separately, as the diversity and
abundance were higher in the IBS group but lower for the
Dice similarity index. Among the selected 20 phylotypes, 3
different genera and 12 species were matched (.97%) with
either the type strains or isolates from fermented foods.
Qin et al. (2010) reported that the abundance of many
bacteria varies greatly within individuals over a period
of time and even within the phylum level. It has been
recognized that probiotic bacteria help human digestive
health. However, modern and advanced tools have
improved our understanding of bacterial niches and the
influence of metabolites. It is understood that the colonic
environment has different nutritional patterns and micro-
bial ecosystems, which has a relationship with metabolic
niches. The increased level of faecal D-alanine produced by
lactic acid bacteria modulates the immune system in a
colitis animal model (De Vos, 2005). The elevated levels of
purine in faecal metabolites suggested extensive glycogen-
olysis and glycolysis; it also indicated increased microbial
activity in either the proliferation or degradation of
bacterial cells. In contrast, qPCR revealed that the quantity
of lactobacilli was lower in nIBS patients than in the
normal gut, but it was higher in IBS patients, and it has
been suggested that lactobacilli and the secreted organic
acids may cause IBS symptoms (Tana et al., 2010). The low
level of alanine and pyroglutamic acid in nIBS indicates
lowered bacterial protease and peptide catabolism, whereas
Lactobacillus activity was increased in IBS, as evidenced by
the elevated levels of faecal alanine released by protein
catabolism (Romick-Rosendale et al., 2009). GI tract pro-
teins are partially hydrolysed as a result of the acidic
conditions of the GI tract and produce peptides, which are
then broken down by gut microbial proteases to release
amino acids (Romick-Rosendale et al., 2009). There are
two possible reasons for the elevated levels of faecal amino
acids: one is catabolism of peptides by the higher bacterial
load; the second is malabsorption of amino acids in IBS
patients. The elevated level of gut bacteria is also reflected
in energy metabolism changes, thus stimulating gut
carbohydrate metabolism. When the carbohydrates and
free amino acids are replaced by protein/peptides, the
fermented phenolic compounds were increased in the
faeces. Lactobacilli produce pyroglutamic acid, bacteriocin,
lactic acid and acetic acid, which act as antimicrobials and
also lower the pH levels, thus preventing the coloniza-
tion by other bacterial communities (Engberg et al.,
2000; Salonen et al., 2010). Fermentation of tyrosine by
proteolytic bacteria ends with phenol products. This
metabolic signature is similar to that observed in condi-
tions of stress and trauma under the influence of human
physiological changes.
The low level of alanine and pyroglutamic acid in nIBS
indicates a lowered level of bacterial protease and peptide
catabolism, whereas Lactobacillus activity is increased in
IBS, indicated by the elevated levels of faecal alanine
released by protein catabolism (Romick-Rosendale et al.,
Microbiota and metabolomics of irritable bowel syndrome
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phenyl acetate and hydroxyphenyl propionate, which are
converted from phenylalanine and plant phenolic com-
pounds by Clostridium spp. as intermediates (Winter et al.,
1991). The increased level of aminobutyric acid in IBS was
strongly correlated with the presence of F. prausnitzii,
which was the most significant n-butyrate-producing
gut bacterium, with well-known effects on host energy
metabolism and mucosal integrity (Li et al., 2008; Pryde
et al., 2002).
In conclusion, we systematically examined the microbial
community and metabolites in faecal samples of IBS and
nIBS Korean subjects. Our results demonstrated a clear
discrepancy between the faecal microbial diversity and
richness measured as the presence of 16S rRNA gene
signatures of bacteria and their metabolic activities. Key
bacterial communities were shown to be significantly
different in diversity and dominance between IBS and
nIBS samples. The diversity and quantity were inter-
linked only in the Bacteroidetes, Bifidobacteria and
Lactobacillus groups. The higher levels of amino acids
and phenolic compounds indicated increased bacterial
metabolism and also altered energy by the predominant
gut microbiota.
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